Da32 Life Science Tech Acquisition Corp Cl A (DALS)
Da32 Life Science Tech Acquisition Corp Cl A (DALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 826 | 599 | -385 | -771 | -303 |
| Accounts payable and accrued liabilities | -1 | 1 | 1 | 0 | 32 |
| Other Working Capital | 345 | 1,207 | 631 | 182 | 74 |
| Other Operating Activity | -1,565 | -2,903 | -1,181 | -175 | -62 |
| Operating Cash Flow | $-396 | $-1,096 | $-934 | $-764 | $-260 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -70 | -70 | 0 | 0 |
| Financing Cash Flow | $N/A | $-70 | $-70 | $0 | $N/A |
| Beginning Cash Position | 699 | 1,865 | 1,865 | 1,865 | 1,865 |
| End Cash Position | 304 | 699 | 861 | 1,101 | 1,605 |
| Net Cash Flow | $-396 | $-1,166 | $-1,004 | $-764 | $-260 |
| Free Cash Flow | |||||
| Operating Cash Flow | -396 | -1,096 | -934 | -764 | -260 |
| Free Cash Flow | -396 | -1,096 | -934 | -764 | -260 |